167 related articles for article (PubMed ID: 37563306)
1. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
[TBL] [Abstract][Full Text] [Related]
2. Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.
Horn H; Jurinovic V; Leich E; Kalmbach S; Bausinger J; Staiger AM; Kurz KS; Möller P; Bernd HW; Feller AC; Koch K; Klapper W; Stein H; Hansmann ML; Hartmann S; Scheubeck G; Dreyling M; Hiddemann W; Herfarth K; Engelhard M; Rosenwald A; Hoster E; Ott G
Hemasphere; 2022 Sep; 6(9):e767. PubMed ID: 35974958
[TBL] [Abstract][Full Text] [Related]
3. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
4. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.
Zamò A; Pischimarov J; Schlesner M; Rosenstiel P; Bomben R; Horn H; Grieb T; Nedeva T; López C; Haake A; Richter J; Trümper L; Lawerenz C; Klapper W; Möller P; Hummel M; Lenze D; Szczepanowski M; Flossbach L; Schreder M; Gattei V; Ott G; Siebert R; Rosenwald A; Leich E
Leukemia; 2018 Mar; 32(3):685-693. PubMed ID: 28824170
[TBL] [Abstract][Full Text] [Related]
5. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of
Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
[No Abstract] [Full Text] [Related]
7. Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.
Pan Y; Meng B; Sun B; Guan B; Liang Y; Wang H; Hao X; Fu K
Diagn Mol Pathol; 2012 Dec; 21(4):234-40. PubMed ID: 22968395
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
9. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
10. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma.
Kim H; Shin D; Son SM; Cho J; Kim JE; Kim Y; Jeon T; Ko YH
Hum Pathol; 2023 Jun; 136():114-122. PubMed ID: 37054783
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
[TBL] [Abstract][Full Text] [Related]
13. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
[TBL] [Abstract][Full Text] [Related]
14. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
15. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
[TBL] [Abstract][Full Text] [Related]
16. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
Los-de Vries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
Blood Adv; 2022 Sep; 6(18):5482-5493. PubMed ID: 35816682
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
[TBL] [Abstract][Full Text] [Related]
18. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
19. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
Leich E; Salaverria I; Bea S; Zettl A; Wright G; Moreno V; Gascoyne RD; Chan WC; Braziel RM; Rimsza LM; Weisenburger DD; Delabie J; Jaffe ES; Lister A; Fitzgibbon J; Staudt LM; Hartmann EM; Mueller-Hermelink HK; Campo E; Ott G; Rosenwald A
Blood; 2009 Jul; 114(4):826-34. PubMed ID: 19471018
[TBL] [Abstract][Full Text] [Related]
20. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.
Schraders M; de Jong D; Kluin P; Groenen P; van Krieken H
J Pathol; 2005 Feb; 205(3):329-35. PubMed ID: 15682435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
